GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (HKSE:01167) » Definitions » GF Value

Jacobio Pharmaceuticals Group Co (HKSE:01167) GF Value : HK$1.54 (As of Mar. 03, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co GF Value?

As of today (2025-03-03), Jacobio Pharmaceuticals Group Co's share price is HK$2.35. Jacobio Pharmaceuticals Group Co's GF Value is HK$1.54. Therefore, Jacobio Pharmaceuticals Group Co's Price-to-GF-Value for today is 1.53. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Jacobio Pharmaceuticals Group Co is Significantly Overvalued.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

  1. We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
  2. We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
  3. Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.

Please note that "Possible Value Trap, Think Twice" applies to companies that appear significantly undervalued but are either experiencing a long-term business decline or facing financial distress.


Jacobio Pharmaceuticals Group Co  (HKSE:01167) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" applies to companies that appear significantly undervalued but are either experiencing a long-term business decline or facing financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) A sufficient margin of safety exists only when the stock is undervalued.

Jacobio Pharmaceuticals Group Co's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=2.35/1.54
=1.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jacobio Pharmaceuticals Group Co GF Value Related Terms

Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Jacobio Pharmaceuticals Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN
Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.
Executives
Qiming Corporate Gp Vi, Ltd. 2201 Interest of corporation controlled by you
Qiming Venture Partners Vi, L.p. 2101 Beneficial owner
Qiming Gp Vi, L.p. 2201 Interest of corporation controlled by you
Wang Yinxiang 2501 Other
Wang Xiaojie 2307 Founder of a discretionary trust who can infl
Hu Yunyan 2501 Other
Hillhouse Investment Management, Ltd. 2102 Investment manager
Hillhouse Fund Iv, L.p. 2201 Interest of corporation controlled by you
Hh Spr-iii Holdings Limited 2101 Beneficial owner
Shen Zhu 2501 Other
Ultimate Estate Limited 2201 Interest of corporation controlled by you
Treasure Partner International Limited 2501 Other
Gloryviewpharma Ltd 2501 Other
Honourpharma Ltd 2501 Other
Blesspharma Ltd 2501 Other

Jacobio Pharmaceuticals Group Co Headlines

No Headlines